J-Wave syndromes expert consensus conference report: Emerging concepts and gaps in knowledge

Buchang Pharmaceuticals; NHLBI [HL47678]; Wistar and Martha Morris; Sharpe-Strumia Research Foundation; National Natural Science Foundation of China [NSFC-81370289]; Mayo Clinic Windland Smith Rice Comprehensive Sudden Cardiac Death Program; Ministry of Health, Labor and Welfare of Japan for Clinical Research on Intractable Diseases [H24-033, H26-040, H27-032]; Finnish Academy of Science and Sigrid Juselius Foundation, Helsinki, Finland; SPS KAKENHI [24591051, 15K09082]; Ministry of Science and Technology of China [2013BAI09B02, 2013DFB30310]; University of Padua, Italy; Netherlands Cardio-Vascular Research Initiative; Dutch Heart Foundation; Dutch Federation of University Medical Centres; Netherlands Organization for Health Research and Development; Royal Netherlands Academy of Sciences; Agence National de la Recherche, French Government [ANR-10-IAHU-04,]; Gilead Sciences; Gilead Sciences and Buchang Pharma; GlaxoSmithKline; Johnson Johnson; Novartis; Astellas; Pfizer; Medtronic Bakken Research CenterSCI(E)[email protected]